DCF — KETTERING HEALTH TROY
Enterprise Value: $-76.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-76.2M
Enterprise Value
$-24.7M
PV of Cash Flows
$-51.5M
PV of Terminal Value
$-82.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $66.0M | $-4.4M | -7.0% | $-7.2M | $-6.5M |
| Year 2 | $68.0M | $-3.9M | -6.0% | $-6.7M | $-5.6M |
| Year 3 | $70.1M | $-3.3M | -5.0% | $-6.2M | $-4.7M |
| Year 4 | $72.2M | $-3.0M | -4.0% | $-6.1M | $-4.1M |
| Year 5 | $74.3M | $-2.9M | -4.0% | $-6.1M | $-3.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-76.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$64.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.07174065918971638
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5